Impact on Nasopharyngeal Carriage, Acute Otitis Media, Immunogenicity and Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A
Latest Information Update: 07 Sep 2023
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Hepatitis A vaccine inactivated; Hepatitis B vaccine recombinant
- Indications Haemophilus infections; Hepatitis A; Hepatitis B; Otitis media; Pneumonia; Streptococcal infections
- Focus Registrational; Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 28 Jul 2020 Treatment arm was changed from 4 to 8, actual patient number changed.
- 01 Mar 2018 Results assessing vaccine preventable disease incidence using patient data from NCT00861380 and NCT00839254 trials published in the Vaccine
- 30 Apr 2013 Results presented at the 23rd European Congress of Clinical Microbiology and Infectious Diseases.